| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 111.695 | 77 |
| GSM780708 | Untreated after 4 days (C2_1) | 466.977 | 91 |
| GSM780709 | Untreated after 4 days (C3_1) | 435.623 | 91 |
| GSM780719 | Untreated after 4 days (C1_2) | 157.465 | 81 |
| GSM780720 | Untreated after 4 days (C2_2) | 339.243 | 88 |
| GSM780721 | Untreated after 4 days (C3_2) | 343.212 | 89 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 1127.66 | 96 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 751.335 | 94 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 640.844 | 93 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 1486.87 | 97 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 560.323 | 92 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 448.58 | 91 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 181.009 | 83 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 769.892 | 94 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 391.294 | 90 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 201.167 | 84 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 802.224 | 94 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 581.817 | 93 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 831.748 | 95 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 1457.28 | 97 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 873.746 | 95 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 1422 | 97 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 1071.57 | 96 |